¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cytochrome c oxidase complex"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • drug-induced immune complex
    ¾à¹°À¯¹ß¸é¿ªº¹ÇÕü
  • dentoalveolar complex
    Ä¡¾ÆÀÌÆ²º¹ÇÕ±¸Á¶
  • exstrophy-epispadias complex
    ¹æ±¤¿Ü¹ø¿äµµ»ó¿­º¹ÇÕ
  • ethmomaxillary complex
    ¹úÁýÀ§ÅλÀº¹ÇÕü, »ç°ñ»ó¾Çº¹ÇÕü
  • father complex
    ¾Æ¹öÁöÄÞÇ÷º½º
  • factor IX complex
    Á¦9ÀÎÀÚº¹ÇÕü
  • Golgi complex
    °ñÁöº¹ÇÕü
  • histocompatibility complex
    Á¶Á÷ÀûÇÕ¼ºº¹ÇÕü
  • HLA complex
    HLAº¹ÇÕü
  • human leukocyte antigen complex
    »ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕü
  • human leukocyte antigen complex gene
    »ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕüÀ¯ÀüÀÚ
  • immune complex
    ¸é¿ªº¹ÇÕü
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³°ú¹Î¼º
  • immune-complex disease
    ¸é¿ªº¹ÇÕüº´
  • inferiority complex
    ¿­µîÄÞÇ÷º½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • father complex
    ¾Æ¹öÁöÄÞÇ÷º½º
  • Golgi¡¯s complex
    °ñÁöº¹ÇÕü
  • human leukocyte antigen complex
    »ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕü
  • immune complex
    ¸é¿ªº¹ÇÕü
  • inferiority complex
    ¿­µîÄÞÇ÷º½º, ¿­µî°¨
  • junctional complex
    ¿¬Á¢º¹ÇÕü
  • major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • Merkel cell-neurite complex
    Ã˰¢¼¼Æ÷½Å°æµ¹±âº¹ÇÕü
  • minor histocompatibility complex
    ºÎÁ¶Á÷ÀûÇÕº¹ÇÕü
  • mother complex
    ¾î¸Ó´ÏÄÞÇ÷º½º
  • mother-infant complex
    ¸ðÀÚÄÞÇÁ·º½º
  • primary complex
    Ãʱ⺯ȭ±º, ¿ø¹ßº¹ÇÕü
  • primary inoculation complex
    ¿ø¹ßÁ¢Á¾º¹ÇÕü
  • synaptonemal complex
    ¿¬Á¢½Çº¹ÇÕü
  • immune-complex disease
    ¸é¿ªº¹ÇÕüº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦È°¼ºÁ¦º¹ÇÕü
  • amylase complex with immunoglobulin = macroamylase
    ¸é¿ª±ÛºÒ¸°¾Æ¹Ð¶óÁ¦º¹ÇÕü=¸¶Å©·Î¾Æ¹Ð¶óÁ¦
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ÀÀ°í°áÇÕü
  • antigen-antibody complex
    Ç׿ø-Ç×üº¹ÇÕü
  • antigen-antibody complex, soluble
    ¼ö¿ë¼º Ç׿ø-Ç×üº¹ÇÕü
  • ghon complex
    °ï º¹ÇÕü, Ghon º¹ÇÕü
  • globulin complex with amylase
    ¾Æ¹Ð¶óÁ¦±Û·ÎºÒ¸°º¹ÇÕü
  • golgi complex
    °ñÁöº¹ÇÕü
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • immune complex
    ¸é¿ªº¹ÇÕü.
  • immune complex
    ¸é¿ªº¹ÇÕü
  • immune complex disease
    ¸é¿ªº¹ÇÕüº´.
  • immune complex measurement
    ¸é¿ªº¹ÇÕÃ¼ÃøÁ¤
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³ °ú¹Î¹ÝÀÀ
  • immune complex urticaria
    ¸é¿ªº¹Çյε巯±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • monoamine oxidase inhibitor
    ¸ð³ë¾Æ¹Î ¿Á½Ã´ÙÁ¦ ¾ïÁ¦Á¦.
  • monoamine oxidase inhibitor (= MAOI)
  • monoamine oxidase(MAO) inhibitors
  • nadph oxidase
    NADPH »êÈ­È¿¼Ò(¡­ß«ûùý£áÈ)
  • oxidase
    »êÈ­È¿¼Ò(ß«ûùý£áÈ), ¿Á½Ãµ¥À̽º.
  • oxidase positive
    »êÈ­È¿¼Ò¾ç¼º(¡­åÕàõ).
  • oxidase reaction
    »êÈ­È¿¼Ò¹ÝÀÀ(¡­Úãëë).
  • oxidase-positive glucose fermenter
    »êÈ­È¿¼Ò¾ç¼º Æ÷µµ´ç¹ßÈ¿(Û£ý£)ü
  • oxidation enzyme =oxidase
    »êÈ­È¿¼Ò(ß« ûùý£áÈ).
  • p-450 mixed function oxidase
    P-450º¹ÇÕ±â´É»êÈ­È¿¼Ò(¡­ùêѦÒöß«ûùý£áÈ)
  • xanthine oxidase
    »êƾ»êÈ­È¿¼Ò
  • xanthine oxidase
    À鯾»êÈ­È¿¼Ò.
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦È°¼ºÁ¦º¹ÇÕü
  • agr complex
    AGR º¹ÇÕü(¡­ÜÜùêô÷)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • closed-promoter complex
    ´ÝÈùÇÁ·Î¸ðÅÍ º¹ÇÕ¹°(ÜÜùêÚª)
  • complex
    º¹ÇÕ¹°(ÜÜùêÚª)
  • complex glycoproteins
    º¹ÇÕ ´ç´Ü¹éÁú(ÜÜùêÓØÓ±ÛÜòõ)
  • complex hapten
    º¹ÇÕ(ÜÜùê) ÇÕÅÙ
  • complex ion
    º¹ÇÕ(ÜÜùê) ÀÌ¿Â
  • complex lipid
    º¹ÇÕÁöÁú(ÜÜùêò·òõ)
  • complex locus
    º¹ÇÕºÎÀ§(ÜÜùêÝ»êÈ)
  • complex medium
    º¹ÇÕ ¹è¾ç¾×(ÜÜùêÛÆå×äû)
  • complex oligosaccharides
    º¹ÇÕ(ÜÜùê) ¿Ã¸®°í»çÄ«¶óÀ̵å
  • complex RNA
    º¹ÇÕ(ÜÜùê) RNA
  • complex virion
    º¹ÇÕ(ÜÜùê) ºñ¸®¿Â
  • covalent enzyme-substrate complex
    È¿¼Ò±âÁú °øÀ¯°áÇÕü(ý£áÈÐñòõÍìêóÌ¿ùêô÷) (ÔÒ) enzymesubstrate compound
  • dead-end complex
    Á¾¸»º¹ÇÕü(ðûØÇÜÜùêô÷)
  • enzyme-bridge complex
    È¿¼Ò°¡±³ º¹ÇÕü (ý£áÈÊ­ÎéÜÜùêô÷)
  • enzyme complex
    È¿¼Òº¹ÇÕü (ý£áÈÜÜùêô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
MAC MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce...
QRS in electrocardiography, the complex consisting of Q, R, and S waves, corresponding to depolarization...
SFC soluble fibrin complex; soluble fibrin-fibrinogen complex; spinal fluid count
CMO Corticosteroid Methyl-Oxidase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CYP cytochrome P
CYT Cytochrome
CYP Cytochrome P 450
Cyt P-450 Cytochrome P-450
CYP1A1 Cytochrome P-450 1A1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • coordination complex
    ¹èÀ§Âø¿°, ¹èÀ§ º¹ÇÕ¹°, ¹èÀ§ °áÇÕ º¹ÇÕü
  • disk-condyle complex
    ¿øÆÇ °úµÎ º¹ÇÕü
  • drug-induced immune complex
    ¾àÁ¦ À¯¹ß¼º ¸é¿ª º¹ÇÕü
  • ego-alien complex
    ÀÚ¾Æ ÀÌÁú ÄÄÇ÷º½º
  • electra complex
    ¿¤·ºÆ®¶ó ÄÞÇ÷º½º
    ÇÁ·ÎÀ̵åÀÇ ¼º°Ý ±¸Á¶·ÐÀÇ ¹ß´Þ ´Ü°è Áß ³²±Ù±âÀÎ 3¼¼¿¡¼­ 6¼¼ »çÀÌÀÇ ¿©ÀÚ ¾ÆÀ̰¡ ¾î¸Ó´Ï¸¦ ¾Æ¹öÁöÀÇ ¼ºÀû °ü½ÉÀÇ °æÀïÀÚ·Î º¸°Ô µÇ°í ¾î¸Ó´Ï¸¦ µÎ·Á¿öÇÏ°Ô µÇ¾î ¾î¸Ó´Ï¸¦ ¹è°ÝÇÏ°í ¾Æ¹öÁö¸¦ »ç¸ðÇÏ´Â Çö»óÀ¸·Î ¾î¸Ó´Ï¿ÍÀÇ µ¿ÀϽð¡ ¿©¾ÆÀÇ ºÒ¾ÈÀ» ÇØ°áÇØ ÁÖ´Â °ÍÀ¸·Î º¸ÀδÙ.
  • immune complex
    ¸é¿ª º¹ÇÕü
    Ç׿ø°ú Ç×üÀÇ Æ¯Á¤ °áÇÕ¹°. ¹ÙÀÌ·¯½º³ª ¼¼±Õ µî À̹°ÀÇ Ä¨ÀÔ¿¡ ´ëÇØ¼­ »ýü°¡ »ý»êÇÑ Ç×ü´Â À̹°ÀÎ Ç׿ø°ú °áÇÕÇÏ¿© ¸é¿ª º¹ÇÕü¸¦ ¸¸µç´Ù. À̴ Ž½Ä ¼¼Æ÷³ª º¸Ã¼¸¦ Ȱ¼ºÈ­ÇÏ¿© À̹°ÀÌ ¹«ÇØÇÑ °ÍÀ¸·Î ºÐÇØÇÏ´Â °ÍÀ» µµ¿Í »ýü ¹æ¾î¿¡ µµ¿òÀ» ÁØ´Ù. Á¶Á÷ Àå¾ÖÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¸é¿ª º¹ÇÕ¼º ÁúȯÀ» ÀÏÀ¸Å°±âµµ ÇÑ´Ù.
  • immune complex-mediated
    ¸é¿ª º¹ÇÕü ¸Å°³¼º
  • intralaminar complex
    Ãþ³» º¹ÇÕü
  • major histocompatibility complex
    ÁÖ Á¶Á÷ ÀûÇÕü, ÁÖ Á¶Á÷ ÀûÇÕ º¹ÇÕü
    ÀÎü Á¶Á÷ÇüÀ» °áÁ¤ÇÏ´Â À¯ÀüÀÚ°¡ 6¹ø ¿°»öüÀÇ ÀÛÀº ºÐÀý¿¡ º¹ÇÕü¸¦ Çü¼ºÇϰí À־ ÀÌ À¯ÀüÀÚ ¿µ¿ªÀ» À̸£´Â ¿ë¾î.
  • mother, complex
    ¸ð º¹ÇÕü
  • complex neutrocclusion
    º¹ÇÕ Áß¼º ±³ÇÕ
    ¾È¸ð¿Í º¹ÀâÇÑ ±³Á¤ Ä¡·á¸¦ µ¿¹ÝÇÏ´Â Áß¼º ±³ÇÕ.
  • nasomaxillary complex
    ºñ »ó¾Ç º¹ÇÕü
  • nitrogenase complex
    Áú¼Ò °íÁ¤ È¿¼Ò º¹ÇÕü
  • Oedipus complex
    ¿ÀÀ̵ðǪ½º ÄÞÇ÷º½º
    ÇÐ·É Àü±â ¾Æµ¿ÀÌ ¹Ý´ë¼ºÀÇ ºÎ¸ð¸¦ È¥ÀÚ¼­ ¼ÒÀ¯ÇÏ°í ½ÍÀº ¿å¸ÁÀ» °¡Áö¸ç, °°Àº ¼ºÀÇ ºÎ¸ð¿¡°Ô °æÀï Àǽİú ÁúÅõ ÀǽÄÀ» °®°Ô µÇ´Â ½É¸®Àû Çö»ó.
  • olivary complex
    ¿Ã¸®ºê º¹ÇÕü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
cytochrome p-450 cyp11b2 <enzyme> A multifunctional enzyme that catalyses the conversion of corticosterone to 18-hydroxycorticosterone and the subsequent conversion of 18-hydroxycorticosterone to aldosterone.
Registry number: EC 1.14.99.-
(12 Dec 1998)
cytochrome p-450 cyp1a1 <enzyme> A cytochrome p-450 enzyme capable of activating procarcinogenic polycyclic hydrocarbons and halogenated aromatic hydrocarbons into mutagenic compounds. Ethoxyresorufin acts as a substrate for cyp1a1 and measurement of ethoxyresorufin o-deethylase provides a more direct method of detection for this enzyme.
Registry number: EC 1.-
(12 Dec 1998)
cytochrome p-450 cyp1a2 <enzyme> A polycyclic aromatic hydrocarbon-inducible cytochrome which is of significant clinical interest due to the large number of drug interactions associated with induction and inhibition of theophylline. Caffeine is considered to be a model substrate for this enzyme. It also metabolises theophylline and antipyrene. Environmental factors including cigarette smoking, charbroiled meat, cruciferous vegetables, and a number of drugs including phenytoin, phenobarbital, and omeprazole produce increases in cyp1a2 activity.
Registry number: EC 1.-
(12 Dec 1998)
cytochrome p-450 cyp2b1 <enzyme> A major cytochrome p-450 enzyme which is inducible by phenobarbital in both the liver and small intestine. It is active in the metabolism of compounds like pentoxyresorufin, testosterone, and androstenedione. Cyp2b1 also mediates the activation of cyclophosphamide and ifosfamide to mutagens.
Registry number: EC 1.-
(12 Dec 1998)
cytochrome p-450 cyp2d6 <enzyme> A polymorphic enzyme that catalyses the hydroxylation of debrisoquine. It also metabolises several antidepressants and neuroleptics. This enzyme is deficient in up to 10 percent of the population.
Registry number: EC 1.14.99.-
(12 Dec 1998)
cytochrome p-450 cyp2e1 <enzyme> A polymorphic enzyme that activates carcinogenic n-nitrosamines, benzene, urethane, and other low molecular weight compounds. It is inducible by ethanol and metabilises alcohol. Experimentally, it is used to study the effects of ethanol usage and withdrawal via enzyme markers such as n-nitrosodimethylamine demethylase.
Registry number: EC 1.5.99.-
(12 Dec 1998)
cytochrome P-450-dependent digitoxin 12beta-hydroxylase <enzyme> Isolated from digitalis lantata cell cultures
Registry number: EC 1.14.99.-
Synonym: digitoxin 12beta-hydroxylase
(26 Jun 1999)
cytochrome P-450SCC Cholesterol monooxygenase (side chain cleaving).
Origin: 450 nm, the absorption maximum that the CO compound of the reduced pigment exhibits
(05 Mar 2000)
cytochrome peroxidase A haemoprotein enzyme catalyzing the reaction between H2O2 and 2 ferrocytochrome c to yield 2ferricytochrome c and 2H2O.
(05 Mar 2000)
cytochrome reductase <enzyme> A flavoprotein that catalyses the reduction of haem-thiolate-dependent monooxygenases and is part of the microsomal hydroxylating system. Its physiological acceptor is probably cytochrome p-450.
Chemical name: NADPH:ferrihemoprotein oxidoreductase
Registry number: EC 1.6.2.4
(12 Dec 1998)
cytochrome reductases <enzyme> Registry number: EC 1.6.2.
(12 Dec 1998)
cytochrome system The mitochondrial electron transport chain.
(18 Nov 1997)
hexopyranoside:cytochrome c oxidoreductase <enzyme> Hexopyranoside:cytochrome c oxidoreductase forms 3-keto hexopyranoside
Registry number: EC 1.1.2.-
(26 Jun 1999)
pyruvate dehydrogenase (cytochrome) An oxidoreductase catalyzing reaction between ferricytochrome b1 and pyruvate to yield acetate and CO2, and ferrocytochrome b1.
(05 Mar 2000)
NADH-cytochrome P-450 reductase <enzyme> A component of the cytochrome p-450sca monoxygenase system
Registry number: EC 1.6.2.-
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á